Article Text

PDF

CSCO joins ESMO Open—Cancer Horizons
  1. Christoph C Zielinski1,
  2. Yi-Long Wu2,3
  1. 1Department of Medicine I, Clinical Division of Oncology, Vienna, Austria
  2. 2Guangdong Lung Cancer Institute, Guangzhou, Guangdong, People's Republic of China
  3. 3Chinese Society of Clinical Oncology (CSCO), Houston, Texas, USA
  1. Correspondence to Dr Christoph C Zielinski; christoph.zielinski{at}meduniwien.ac.at

Statistics from Altmetric.com

ESMO Open—Cancer Horizons is happy to announce its association with the Chinese Society of Clinical Oncology (CSCO). After intensive personal contacts between the CSCO President Professor Y-LW and the leadership of the European Society for Medical Oncology (ESMO) as well as the Editor-in-Chief of ESMO Open—Cancer Horizons, an agreement on this potentially very fruitful association was signed on 8 October 2016 during the recent scientifically exciting and highly successful ESMO Annual Meeting, by the president of ESMO, Fortunato Ciardiello, and of CSCO, Professor Y-LW.

It was the recent ESMO Annual Meeting which impressively proved the ability of ESMO to give scientists and clinicians an appropriate stage to launch and define new treatment standards acknowledged by important scientific journals which have simultaneously published many communications given during the meeting as full-length papers. Thus, it is our belief that ESMO has the right format to represent an important player in oncology in a truly global context.

Since its launch in January 2016, ESMO Open—Cancer Horizons has flourished and grown considerably. This is demonstrated by the number of submitted editorials, research papers, reviews and podcasts (over 100 submissions to date, with 65 papers published online so far), and also in the number of downloaded papers (totalling almost 50 000, between January and September 2016) and page impressions (over 60 000 since launch). The manuscript turnaround time is very swift with a mean of 21 days from submission to acceptance and 23 days from acceptance to publication.

Thus, it was only fair to seek the further expansion of ESMO Open—Cancer Horizons and seek for associations with national societies in an attempt to bid the ESMO ambition to be a society present ‘across oncology, worldwide’. ESMO Open—Cancer Horizons was happy to announce its proud association with the Italian Association of Medical Oncology (AIOM) recently,1 and now undertakes the next and very important step to liaise with Asian colleagues through an association with CSCO which flourishes remarkably and harbours an ever-growing number of important data. CSCO is a society of 12 000 members and holds an annual conference in Xiamen, China, which was recently attended by 23 000 participants and where a total number of 1200 scientific communications were presented and discussed by clinicians and scientists from both, China and guests from abroad. Thus, it is clear that CSCO commands a tremendously high potential regarding future collaborations on a variety of issues which must bring the two societies—ESMO and CSCO—even closer together than witnessed already now.

ESMO Open—Cancer Horizons, being one of the two journals ESMO publishes, remains happy to receive and publish papers from China in all possible formats after an the usual peer-review process which applies to all submissions. Together, we look forward to a bright future leading to ever-evolving insights into the biology of various cancers which will ultimately benefit our patients, their relatives and the entire community.

Reference

View Abstract

Footnotes

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.